75 related articles for article (PubMed ID: 17316994)
1. SB203580 enhances interleukin-1 receptor antagonist gene expression in IFN-gamma-stimulated BV2 microglial cells through a composite nuclear factor-kappaB/PU.1 binding site.
Park JS; Jung SH; Seo H; Kim HS
Neurosci Lett; 2007 Apr; 416(2):169-74. PubMed ID: 17316994
[TBL] [Abstract][Full Text] [Related]
2. Leptin activates the promoter of the interleukin-1 receptor antagonist through p42/44 mitogen-activated protein kinase and a composite nuclear factor kappa B/PU.1 binding site.
Dreyer MG; Juge-Aubry CE; Gabay C; Lang U; Rohner-Jeanrenaud F; Dayer JM; Meier CA
Biochem J; 2003 Mar; 370(Pt 2):591-9. PubMed ID: 12423202
[TBL] [Abstract][Full Text] [Related]
3. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways.
Kim YJ; Hwang SY; Oh ES; Oh S; Han IO
J Neurosci Res; 2006 Oct; 84(5):1037-46. PubMed ID: 16881054
[TBL] [Abstract][Full Text] [Related]
4. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
[TBL] [Abstract][Full Text] [Related]
5. Secretory interleukin-1 receptor antagonist gene expression requires both a PU.1 and a novel composite NF-kappaB/PU.1/ GA-binding protein binding site.
Smith MF; Carl VS; Lodie T; Fenton MJ
J Biol Chem; 1998 Sep; 273(37):24272-9. PubMed ID: 9727052
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory responses of corneal epithelial cells to Pseudomonas aeruginosa infection.
Zhang J; Wu XY; Yu FS
Curr Eye Res; 2005 Jul; 30(7):527-34. PubMed ID: 16020286
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury.
Wang XJ; Kong KM; Qi WL; Ye WL; Song PS
Acta Pharmacol Sin; 2005 Aug; 26(8):934-42. PubMed ID: 16038625
[TBL] [Abstract][Full Text] [Related]
8. The NF-kappaB, p38 MAPK and STAT1 pathways differentially regulate the dsRNA-mediated innate immune responses of epidermal keratinocytes.
Dai X; Sayama K; Tohyama M; Shirakata Y; Yang L; Hirakawa S; Tokumaru S; Hashimoto K
Int Immunol; 2008 Jul; 20(7):901-9. PubMed ID: 18492658
[TBL] [Abstract][Full Text] [Related]
9. Synergistic expression of inducible nitric oxide synthase by phorbol ester and interferon-gamma is mediated through NF-kappaB and ERK in microglial cells.
Han IO; Kim HS; Kim HC; Joe EH; Kim WK
J Neurosci Res; 2003 Sep; 73(5):659-69. PubMed ID: 12929133
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB.
Wong CK; Cheung PF; Ip WK; Lam CW
Am J Respir Cell Mol Biol; 2005 Aug; 33(2):186-94. PubMed ID: 15860795
[TBL] [Abstract][Full Text] [Related]
11. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase.
Ma KK; Ogawa T; de Bold AJ
J Mol Cell Cardiol; 2004 Apr; 36(4):505-13. PubMed ID: 15081310
[TBL] [Abstract][Full Text] [Related]
12. Blockade of p38 mitogen-activated protein kinase pathway inhibits interleukin-6 release and expression in primary neonatal cardiomyocytes.
Chae H; Lee J; Byun J; Jung W; Kwak Y; Chae S; Kim H
Res Commun Mol Pathol Pharmacol; 2001; 110(3-4):209-28. PubMed ID: 12760489
[TBL] [Abstract][Full Text] [Related]
13. P38 mitogen-activated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model.
Dong X; Liu Y; Du M; Wang Q; Yu CT; Fan X
Eur J Cardiothorac Surg; 2006 Jul; 30(1):77-84. PubMed ID: 16723252
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 and cyclic AMP stimulate release of cathepsin B in human osteoblasts.
Chae HJ; Ha KC; Lee GY; Yang SK; Yun KJ; Kim EC; Kim SH; Chae SW; Kim HR
Immunopharmacol Immunotoxicol; 2007; 29(2):155-72. PubMed ID: 17849265
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.
Gabay C; Smith MF; Eidlen D; Arend WP
J Clin Invest; 1997 Jun; 99(12):2930-40. PubMed ID: 9185517
[TBL] [Abstract][Full Text] [Related]
16. A new anti-inflammatory agent KL-1037 represses proinflammatory cytokine and inducible nitric oxide synthase (iNOS) gene expression in activated microglia.
Kim WK; Jang PG; Woo MS; Han IO; Piao HZ; Lee K; Lee H; Joh TH; Kim HS
Neuropharmacology; 2004 Aug; 47(2):243-52. PubMed ID: 15223303
[TBL] [Abstract][Full Text] [Related]
17. Enteroaggregative Escherichia coli flagellin-induced interleukin-8 secretion requires Toll-like receptor 5-dependent p38 MAP kinase activation.
Khan MA; Kang J; Steiner TS
Immunology; 2004 Aug; 112(4):651-60. PubMed ID: 15270737
[TBL] [Abstract][Full Text] [Related]
18. LY294002 inhibits interferon-gamma-stimulated inducible nitric oxide synthase expression in BV2 microglial cells.
Hwang SY; Jung JS; Lim SJ; Kim JY; Kim TH; Cho KH; Han IO
Biochem Biophys Res Commun; 2004 Jun; 318(3):691-7. PubMed ID: 15144893
[TBL] [Abstract][Full Text] [Related]
19. Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production.
Yamakawa T; Eguchi S; Matsumoto T; Yamakawa Y; Numaguchi K; Miyata I; Reynolds CM; Motley ED; Inagami T
Endocrinology; 1999 Aug; 140(8):3562-72. PubMed ID: 10433212
[TBL] [Abstract][Full Text] [Related]
20. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons.
Goh KC; Haque SJ; Williams BR
EMBO J; 1999 Oct; 18(20):5601-8. PubMed ID: 10523304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
